ストックスクリーナーアプリを入手
28.65
3.06%
0.85
前日終値:
$27.80
開ける：
$27.5
24時間の取引高:
1.91M
Relative Volume:
0.82
時価総額：
$3.62B
収益：
$715.22M
当期純損益:
$-250.10M
株価収益率:
-14.11
EPS:
-2.03
ネットキャッシュフロー:
$-205.58M
1週間 パフォーマンス:
+2.14%
1か月 パフォーマンス:
+18.10%
6か月 パフォーマンス:
+14.37%
1年 パフォーマンス:
-24.17%
1日の値動き範囲:
$27.26
$28.67
1週間の範囲:
$27.14
$28.67
52週間の値動き範囲:
$16.10
$41.94
Apellis Pharmaceuticals Inc Stock (APLS) Company Profile
名前
Apellis Pharmaceuticals Inc
セクター
電話
617-977-5700
住所
100 FIFTH AVENUE, WALTHAM, KY
APLS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APLS
Apellis Pharmaceuticals Inc
|
28.65 | 3.56B | 715.22M | -250.10M | -205.58M | -2.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Apellis Pharmaceuticals Inc Stock (APLS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-09 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-09 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-17 | ダウングレード | Goldman | Buy → Neutral |
| 2024-11-21 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-10-25 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-10-16 | 開始されました | William Blair | Outperform |
| 2024-05-31 | 開始されました | Piper Sandler | Neutral |
| 2024-02-05 | アップグレード | Jefferies | Hold → Buy |
| 2023-12-14 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-11-09 | 開始されました | Goldman | Buy |
| 2023-11-02 | 開始されました | Mizuho | Neutral |
| 2023-10-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-15 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-08-29 | 繰り返されました | Citigroup | Buy |
| 2023-08-03 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2023-08-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-01-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-11-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-19 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-17 | 再開されました | Stifel | Buy |
| 2022-04-14 | ダウングレード | ROTH Capital | Neutral → Sell |
| 2021-12-08 | 開始されました | Wells Fargo | Overweight |
| 2021-11-29 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2021-09-10 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-09-10 | 繰り返されました | Credit Suisse | Neutral |
| 2021-09-10 | 繰り返されました | Needham | Buy |
| 2021-09-10 | 繰り返されました | Oppenheimer | Outperform |
| 2021-09-10 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-08-19 | 開始されました | Jefferies | Buy |
| 2021-08-19 | アップグレード | Wedbush | Neutral → Outperform |
| 2021-05-21 | 開始されました | UBS | Buy |
| 2021-04-16 | 開始されました | Goldman | Buy |
| 2020-11-19 | 開始されました | Needham | Buy |
| 2020-09-01 | 開始されました | Stifel | Buy |
| 2020-07-20 | 開始されました | ROTH Capital | Buy |
| 2020-06-17 | 開始されました | BTIG Research | Neutral |
| 2020-04-01 | 開始されました | Raymond James | Strong Buy |
| 2020-03-31 | 開始されました | BMO Capital Markets | Outperform |
| 2020-03-11 | アップグレード | Wedbush | Underperform → Neutral |
| 2020-01-07 | 開始されました | SVB Leerink | Mkt Perform |
| 2019-12-19 | 開始されました | BofA/Merrill | Buy |
| 2019-11-22 | 開始されました | Wedbush | Underperform |
| 2019-11-05 | 開始されました | Credit Suisse | Neutral |
| 2019-08-01 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2019-07-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-03-29 | 開始されました | Robert W. Baird | Outperform |
| 2019-01-23 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-07-30 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-05-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-04-12 | ダウングレード | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-02-08 | 開始されました | B. Riley FBR, Inc. | Buy |
すべてを表示
Apellis Pharmaceuticals Inc (APLS) 最新ニュース
Order flow analysis tools used on Apellis Pharmaceuticals Inc.July 2025 Update & Safe Entry Point Alerts - Newser
Analyzing drawdowns of Apellis Pharmaceuticals Inc. with statistical toolsJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - Newser
Transcript : Apellis Pharmaceuticals, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 08 - MarketScreener
Can Apellis Pharmaceuticals Inc. deliver alphaJuly 2025 Short Interest & Free Real-Time Market Sentiment Alerts - khodrobank.com
Apellis Pharmaceuticals Inc. stock retracement – recovery analysisChart Signals & Reliable Price Action Trade Plans - Newser
Backtesting results for Apellis Pharmaceuticals Inc. trading strategiesTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser
Will Apellis Pharmaceuticals Inc. stock benefit from interest rate changesRate Cut & AI Optimized Trading Strategy Guides - Newser
What earnings revisions data tells us about Apellis Pharmaceuticals Inc.July 2025 Action & Weekly Return Optimization Alerts - Newser
Can machine learning forecast Apellis Pharmaceuticals Inc. recoveryMarket Performance Report & Long-Term Capital Growth Strategies - Newser
Apellis Pharma VP Chopas sells $15k in shares - Investing.com
Can trapped investors hope for a rebound in Apellis Pharmaceuticals Inc.Buy Signal & Comprehensive Market Scan Insights - Newser
What’s the MACD signal for Apellis Pharmaceuticals Inc.Trade Risk Assessment & Weekly High Return Forecasts - khodrobank.com
Transcript : Apellis Pharmaceuticals, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 08 - MarketScreener
Analyzing net buyer seller activity in Apellis Pharmaceuticals Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - Newser
What data driven models say about Apellis Pharmaceuticals Inc.’s futureEarnings Miss & Short-Term High Return Strategies - Newser
How is Apellis Pharmaceuticals Inc. managing supply chain issuesWeekly Trend Recap & Growth Focused Stock Reports - khodrobank.com
Should value investors consider Apellis Pharmaceuticals Inc.July 2025 News Drivers & Community Consensus Stock Picks - khodrobank.com
What’s the beta of Apellis Pharmaceuticals Inc. stockQuarterly Earnings Summary & Fast Entry Momentum Alerts - khodrobank.com
Key metrics from Apellis Pharmaceuticals Inc.’s quarterly dataJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - Newser
What’s the profit margin of Apellis Pharmaceuticals Inc.Dollar Strength & Real-Time Stock Movement Alerts - khodrobank.com
Is Apellis Set for a Rebound? - timothysykes.com
Is Apellis Pharmaceuticals Inc. stock a value trap2025 Earnings Impact & High Return Trade Guides - khodrobank.com
Will Apellis Pharmaceuticals Inc. stock recover after recent dropRecession Risk & Safe Capital Investment Plans - Newser
Is Apellis Pharmaceuticals Inc. meeting your algorithmic filter criteriaOptions Play & Consistent Profit Focused Trading Strategies - Newser
Published on: 2025-09-01 23:36:26 - Newser
What the charts say about Apellis Pharmaceuticals Inc. today2025 Performance Recap & Entry Point Strategy Guides - Newser
What to do if you’re stuck in Apellis Pharmaceuticals Inc.Market Activity Summary & Expert Verified Stock Movement Alerts - Newser
How cyclical is Apellis Pharmaceuticals Inc.’s revenue streamMarket Sentiment Report & Entry and Exit Point Strategies - khodrobank.com
Published on: 2025-09-01 19:43:22 - Newser
Real time social sentiment graph for Apellis Pharmaceuticals Inc.Quarterly Trade Review & Reliable Entry Point Alerts - Newser
Has Apellis Pharmaceuticals Inc. found a price floor2025 Market Outlook & Low Drawdown Momentum Trade Ideas - Newser
Apellis Pharmaceuticals Inc. Recovery Gathers Momentum on Chart Signals getLinesFromResByArray error: size == 0 - 강소기업뉴스
Should I hold or sell Apellis Pharmaceuticals Inc. nowExit Point & Breakout Confirmation Trade Signals - khodrobank.com
Is Apellis Pharmaceuticals Inc. reversing from oversold territoryWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
How to track smart money flows in Apellis Pharmaceuticals Inc.July 2025 Trends & Precise Swing Trade Entry Alerts - Newser
Have Insiders Sold Apellis Pharmaceuticals Shares Recently? - simplywall.st
Automated trading signals detected on Apellis Pharmaceuticals Inc.Buy Signal & Safe Capital Investment Plans - Newser
Apellis Pharmaceuticals Inc. stock momentum explained2025 Top Gainers & Smart Allocation Stock Tips - Newser
Using fundamentals and technicals on Apellis Pharmaceuticals Inc.Weekly Trend Summary & Technical Entry and Exit Alerts - Newser
Heatmap analysis for Apellis Pharmaceuticals Inc. and competitorsQuarterly Earnings Summary & Intraday High Probability Setup Alerts - Newser
Apellis Pharmaceuticals Inc (APLS) 財務データ
収益
当期純利益
現金流量
EPS
1.75%
1.11%
大文字化:
|
ボリューム (24 時間):